257 related articles for article (PubMed ID: 38049608)
1. Theory of mind in mild cognitive impairment and Parkinson's disease: The role of memory impairment.
Maggi G; Giacobbe C; Vitale C; Amboni M; Obeso I; Santangelo G
Cogn Affect Behav Neurosci; 2024 Feb; 24(1):156-170. PubMed ID: 38049608
[TBL] [Abstract][Full Text] [Related]
2. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
4. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
Cammisuli DM; Sportiello MT
Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological, neuropsychiatric, and clinical correlates of affective and cognitive theory of mind in Parkinson's disease: A meta-analysis.
Maggi G; Cima Muñoz AM; Obeso I; Santangelo G
Neuropsychology; 2022 Sep; 36(6):483-504. PubMed ID: 35389722
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
7. The impact of executive dysfunctions on Theory of Mind abilities in Parkinson's disease.
Maggi G; Di Meglio D; Vitale C; Amboni M; Obeso I; Santangelo G
Neuropsychologia; 2022 Nov; 176():108389. PubMed ID: 36206823
[TBL] [Abstract][Full Text] [Related]
8. Social Cognition in Rehabilitation Context: Different Evolution of Affective and Cognitive Theory of Mind in Mild Cognitive Impairment.
Rossetto F; Baglio F; Massaro D; Alberoni M; Nemni R; Marchetti A; Castelli I
Behav Neurol; 2020; 2020():5204927. PubMed ID: 32399083
[TBL] [Abstract][Full Text] [Related]
9. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
Goldman JG; Weis H; Stebbins G; Bernard B; Goetz CG
Mov Disord; 2012 Aug; 27(9):1129-36. PubMed ID: 22778009
[TBL] [Abstract][Full Text] [Related]
10. Social Cognition and Cognitive Decline in Patients with Parkinson's Disease.
Alonso-Recio L; Carvajal F; Merino C; Serrano JM
J Int Neuropsychol Soc; 2021 Aug; 27(7):744-755. PubMed ID: 33243315
[TBL] [Abstract][Full Text] [Related]
11. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and Affective Theory of Mind in Mild Cognitive Impairment and Parkinson's Disease: Preliminary Evidence from the Italian Version of the Yoni Task.
Rossetto F; Castelli I; Baglio F; Massaro D; Alberoni M; Nemni R; Shamay-Tsoory S; Marchetti A
Dev Neuropsychol; 2018; 43(8):764-780. PubMed ID: 30299987
[TBL] [Abstract][Full Text] [Related]
13. Social Cognition and Mild Cognitive Impairment in Mid-Stage Parkinson's Disease.
Fernández-Fernández R; Lahera G; Fernández-Rodríguez B; Guida P; Trompeta C; Mata-Marín D; Gasca-Salas C
Behav Sci (Basel); 2024 Jan; 14(2):. PubMed ID: 38392454
[TBL] [Abstract][Full Text] [Related]
14. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
Putcha D; Tremont G
J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
[TBL] [Abstract][Full Text] [Related]
16. The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Young CB; Cholerton B; Smith AM; Shahid-Besanti M; Abdelnour C; Mormino EC; Hu SC; Chung KA; Peterson A; Rosenthal L; Pantelyat A; Dawson TM; Quinn J; Zabetian CP; Montine TJ; Poston KL
Neurology; 2024 Jul; 103(2):e209609. PubMed ID: 38870440
[TBL] [Abstract][Full Text] [Related]
17. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
18. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonian patients with deficits in the dysexecutive spectrum are impaired on theory of mind tasks.
Costa A; Peppe A; Martini M; Coletta K; Oliveri M; Caltagirone C; Carlesimo GA
Behav Neurol; 2013 Jan; 27(4):523-33. PubMed ID: 23242360
[TBL] [Abstract][Full Text] [Related]
20. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease.
Lehrner J; Kogler S; Lamm C; Moser D; Klug S; Pusswald G; Dal-Bianco P; Pirker W; Auff E
Int Psychogeriatr; 2015 Mar; 27(3):357-66. PubMed ID: 25382659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
